SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001214659-23-012349
Filing Date
2023-09-14
Accepted
2023-09-14 16:01:46
Documents
12
Period of Report
2023-09-08
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 o9142318k.htm   iXBRL 8-K 24316
  Complete submission text file 0001214659-23-012349.txt   195831

Data Files

Seq Description Document Type Size
2 XBRL SCHEMA FILE hgen-20230908.xsd EX-101.SCH 2991
3 XBRL LABEL FILE hgen-20230908_lab.xml EX-101.LAB 34240
4 XBRL PRESENTATION FILE hgen-20230908_pre.xml EX-101.PRE 22343
6 EXTRACTED XBRL INSTANCE DOCUMENT o9142318k_htm.xml XML 3283
Mailing Address 830 MORRIS TURNPIKE 4TH FLOOR SHORT HILLS NJ 07078
Business Address 830 MORRIS TURNPIKE 4TH FLOOR SHORT HILLS NJ 07078 (973) 200-3100
HUMANIGEN, INC (Filer) CIK: 0001293310 (see all company filings)

IRS No.: 770557236 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-35798 | Film No.: 231255123
SIC: 2834 Pharmaceutical Preparations